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Introduction
Detailing the planned methods for conducting a systematic 
review in advance of commencing the review is essential in order 
to minimise a range of potential biases1,2. The plan, set out in a 
protocol, should ideally be made available in the public domain 
to facilitate transparency3,4. In addition, registration of key proto-
col details is encouraged as best practice in reporting guidelines5,6 
by publishers like the British Medical Journal (BMJ), Public 
Library of Science (PLoS), and BioMed Central (BMC), and 
is mandated in their instructions to authors by journals such 
as BMC Systematic Reviews, BMJ, BMJ Open, PLoS One, 
and National Institute for Health Research (NIHR) journals.
There are a number of options for putting systematic review 
protocols into the public domain, such as publication in open 
access journals like BMC Systematic Reviews and upload-
ing to open data repositories like the Open Science Framework 
(OSF) (https://osf.io/registries/discover?q=protocols). PROSPERO 
(https://www.crd.york.ac.uk/prospero/) is a facility for regis-
tering key methodological details in advance of carrying out 
a review. Registration on PROSPERO requires completion of an 
internationally agreed minimum dataset for a systematic review 
protocol7,8. Registrants also have the option of uploading their 
protocol or providing a hyperlink to it.
PROSPERO remains the only free, open access registry of sys-
tematic review protocols, making it a single searchable source 
of the protocols of on-going and completed reviews. Uptake 
of registration has increased exponentially and by the end of 
2019 there were over 60,000 registrations in PROSPERO. 
There is evidence that considerably more systematic reviews are 
registered in PROSPERO than have peer-reviewed protocols 
published. In 2016, 1058 records were accepted by PROS-
PERO; in the same time period, only 404 published system-
atic review protocols were identified3. Another study reported 
identifying 20,814 non-Cochrane systematic review protocols 
from web scraping PROSPERO and bibliographic database 
searches. Of these, 924 were only published in journals, 807 
were published in journals and registered in PROSPERO and 
19,890 were only available as a record in PROSPERO9. There is 
further evidence from Ge et al (2018) that of the non-Cochrane 
reviews registered in PROSPERO, only 3% or 4% have a pub-
lished protocol9,10. This means that for a large number of 
reviews a PROSPERO record is likely to be the only source 
providing details of the planned methods.
Published protocols and registration records aim to provide 
transparency in the review process by allowing public access 
to the key pre-specified elements for the conduct of a review. 
One of the stated aims of PROSPERO is to facilitate compari-
son between planned review methods and reported results8. Such 
a comparison enables peer reviewers and other readers of the 
final review to assess for themselves the potential for bias in 
the findings. There is also a steadily growing body of research 
using PROSPERO records to assess the risk of biases in final 
review reports10–15. Given this reliance on the information pro-
vided in PROSPERO records, it is important to understand the 
level of detail provided in records. The focus of this study was 
on the stated aim of PROSPERO to reduce the opportu-
nity for bias by enabling comparison of the completed review 
with what was planned in the protocol8.
The Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses extension for Protocols (PRISMA-P) were 
developed through expert consensus using internationally 
compiled datasets such as PROSPERO and SPIRIT4,6.
Key methodological aspects of a protocol are mandated for 
registration in PROSPERO; other items, mainly administra-
tive fields, are optional7,8. Submissions for registration are not 
subject to any form of peer review or critical appraisal, they 
are simply checked for sense but not methodological rigor. 
Therefore, there is the possibility that PROSPERO records do 
not provide all the necessary information identified by the 
PRISMA-P guidelines to enable comparison with the completed 
systematic review. The registration record may be the only place 
where a priori methods are available for users, in particular peer 
reviewers, to check for potential issues such as selection, out-
come reporting and publication biases. This study investigated 
the extent to which records in PROSPERO, where no protocol or 
other information was available, comply with each of the items 
for reporting of protocols set out in the PRISMA-P guidelines.
Methods
A random sample of PROSPERO registration records were 
assessed against the systematic review protocol reporting cri-
teria set out in the PRISMA-P 2015 checklist4. Key methods 
are provided here with further details available in the protocol 
for this study, which was prepared and made publicly available 
on the OSF, 17 March 2020 (Extended data16).
Study sample of PROSPERO records
A dataset of non-Cochrane PROSPERO records was provided 
by Metaxis, the software managers of PROSPERO. Records 
of reviews defined by the record holder as a health interven-
tion registered on or between 1 January 2018 and 31 December 
2018, were identified.
Cochrane reviews, reviews of animal studies, non-interven-
tion reviews as identified in PROSPERO, i.e. Diagnostic accu-
racy, Prognostic factors, Prevention, Epidemiological reviews 
relevant to health and social care, Public health, Service deliv-
ery in health and social care, Methodological reviews, reviews 
of reviews, and synthesis of qualitative studies, were all 
excluded as PROSPERO and PRISMA-P were developed for 
reviews of interventions. Only records with no evidence from 
the registration record of other protocol related information, 
for example in a published protocol or other links in the PROS-
PERO record, were included and we restricted the data set to 
those records with a single registry entry.
Records from the calendar year 2018 were used to allow time 
for dissemination and adoption of the PRISMA-P guidelines 
published in 2015. A sample of 20% of these records was ran-
domly selected using simple random sampling for assessment 
against the PRISMA-P reporting criteria.
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Assessment tool and scoring
The PRISMA-P checklist recommends 17 numbered items, 
with nine subdivisions, totalling 26 items be reported in a sys-
tematic review protocol4. Seven of the 26 items were excluded 
from the assessment as they would always or never meet regis-
tration requirements in PROSPERO. For example, registration 
is implicit for a record accepted in PROSPERO, and there is no 
field for author contributions or sponsor role so these would 
never be reported. The study assessment tool, developed specifi-
cally for this study as a Google Form, therefore contained 19 of 
the PRISMA-P items. Where the PRISMA-P description for 
an item specified more than one piece of information, the indi-
vidual elements were listed as subsets of the items4,6. This list 
contained 63 elements to be reported.
Where an item was reported or not applicable, a score of 1 was 
assigned. Where the information was not reported this scored 
0. The maximum possible overall score for the PRISMA-P 
listed items was 19 per record. Scores for the breakdown of 
individual elements within the items was also reported, the 
maximum possible score was 63 per record.
Assessment procedure
The researchers undertaking the assessments (AB, ASM, AM, 
SJ, SC, SG) familiarised themselves with both PRISMA-P 
papers4,6. All had previously received training in systematic 
review methods and/or authored at least one systematic review. 
The draft assessment form and accompanying guidance notes 
were revised and finalised during a training session and piloted 
with the aim of achieving greater than 90% agreement.
Two researchers independently compared the information pro-
vided in each PROSPERO record with the relevant items in the 
study assessment tool. Options for decisions were: Reported 
(information provided as per PRISMA-P requirements); Not 
reported (some or all information not provided); and, Not 
applicable (where an item was not relevant to an individual 
record, e.g. a meta-analysis was not planned).
Records were randomly assigned to assessors by first creat-
ing a list of the sampled record unique identification num-
bers and dividing the list into 14 blocks of approximately equal 
size, with each block being assigned a colour. A copy of this list 
together with the block configuration was then placed alongside 
the original list. Seven sub-lists were then created by randomly 
selecting a block from the first list and a block from the sec-
ond list, such that blocks of the same colour were not in the 
same sub-list, and each colour appeared in two sub-lists. 
Each sub-list was then randomly assigned to an assessor.
It was not feasible to blind the researchers to the authors of reg-
istrations in PROSPERO. None of the assessors were authors 
of included registrations. On completion of the pilot assess-
ments and the full set of records, disagreements were resolved 
through discussion or recourse to a third researcher.
The assessment form and the guidance notes are available 
on the OSF (Extended data16).
Analysis
The primary outcome for this study was the compliance of PROS-
PERO registration records to PRISMA-P reporting items. This 
was measured by the total mean score allocated by the two inde-
pendent assessors to each of the 19 items assessed (maximum 
possible score 19) for each record and by the total mean score 
for the individual elements within items (maximum possible 
score 63). Overall scores for the assessed dataset, scores by the 
19 PRISMA-P items and by the 63 elements were the planned 
outcome measures.
For the eligible 2018 records that were assessed and those not 
assessed, demographic data for month of registration, fund-
ing/sponsor, planned meta-analysis, number of authors, stage 
of review at registration, topic and country of review were to 
be reported. Comparisons to identify any association between 
records registered before or after screening started; whether a 
meta-analysis was planned or not; and whether a review was 
funded/sponsored or not and completeness of reporting of items 
were planned.
Deviations from protocol
During piloting of the assessment form, it became clear that it 
would not be possible to assess records for PRISMA-P item 
5a Sources and 5b Sponsor. This would have required separat-
ing sources of financial support from sponsorship or any other 
form of support as reported in the single PROSPERO field, 
which was not possible. This item was therefore removed from 
the assessment form. Instead, a series of regular expression pat-
terns was compared to the list of eligible records to identify 
those where the record contained any indication of funding/ 
sponsorship/support or indicated there was none. These data 
were used in the presentation of demographics and subgroup 
comparison.
Results
The PROSPERO dataset contained 5,313 records for reviews of 
health interventions first accepted in 2018 (excluding Cochrane 
and reviews of animal studies). Applying the other study 
inclusion/exclusion criteria resulted in 2,194 eligible registra-
tion records. The randomly selected sample of 20% for assess-
ment included 439 records. During assessment, six records were 
excluded, for not meeting the inclusion criteria (4), being a 
duplicate (1) or no longer available on PROSPERO (1). Assess-
ments were therefore carried out on 433 PROSPERO records. 
A flow chart of record selection is shown in Figure 1.
Agreement following initial piloting of the assessment form was 
87%; after further discussions and revision of the assessment 
guidance notes and form a second pilot achieved 92% agree-
ment. For all the records assessed, agreement between research-
ers was 90%, all differences were resolved through discussion 
or referral to a third researcher.
Demographic details of the sample of PROSPERO records 
selected for assessment and those not assessed are provided in 
Table 1. The number of authors listed ranged between one 
and 17, with the exception of a single record, included in the 
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assessed sample, where 47 authors were listed. The eligible 
sample for 2018 included records from 67 different countries: 
20 records listed two countries and 15 listed between three and 
nine countries involved in the review. There were no substantial 
differences between the data sets in the month of registration; 
whether any details of funding and/or sponsorship were pro-
vided; whether a meta-analysis was planned or not; the number 
of authors listed per record; stage of review at registration; topic 
of review or country involved in undertaking the review.
None of the PROSPERO records assessed against the eligibil-
ity criteria reported on all elements in each of the items recom-
mended for a systematic review protocol in the PRISMA-P 
guidelines. The mean total score for individual PROSPERO 
records, where 1 point was gained for each of the 19 items in 
the PRISMA-P checklist, was 4.8, the standard deviation 1.8, 
the median 4, and range 2 to 11. Considering all items across all 
the assessed records, only 25% (2081/8227) of the items were 
scored as reported.
The mean total score for individual PROSPERO records 
where 1 point was gained for each of the 63 elements of the 
PRISMA-P reporting guidelines was 33.4, the standard devia-
tion 5.8, the median 33 and the range 18–47. Overall, 53% 
(14,469/27,279) of the elements were considered as reported.
Scoring for 19 PRISMA-P items
The highest scoring item was PRISMA-P 1b which requires 
the protocol to be identified as to whether it is an update of 
a review; the high score was the result of this being a not- 
applicable item for 423 (98%) of the 433 records (Table 2). 
Eligibility criteria (study design, setting, population, intervention, 
Figure 1. Flow chart of record sample identification.
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Table 1. Demographic details of non-sample set and sample set of the eligible 2018 PROSPERO records.
Demographic Records for assessment 
(n = 439)
Records not assessed 
(n = 1755)
Month of registration n (%)
January 45 (10) 168 (10)
February 32 (7) 141 (8)
March 25 (6) 100 (6)
April 35 (8) 122 (7)
May 16 (4) 110 (6)
June 36 (8) 151 (8)
July 54 (12) 188 (11)
August 56(12) 200 (11)
September 31 (7) 151 (9)
October 37 (8) 138 (8)
November 37 (8) 160 (9)
December 35 (8) 126 (7)
Funding/support indicated n (%) 386 (88) 1572 (90)
Meta-analysis planned n (%) 253 (58) 1064 (61)
Number of listed authors (mean, range) 4.1 (0 – 47*) 3.9 (0 – 17)
Stage of review** 
n (%)
Not Started 96 (22) 385 (22)
Searches Start 65(15) 283 (16)
Searches Complete 12 (3) 57 (3)
Pilot Selection Start 56 (13) 252 (14)
Pilot Selection Complete 16 (4) 50 (3)
Screening Start 80 (19) 285 (16)
Screening Complete 13 (3) 56 (3)
Extraction Start 93 (21) 376 (21)
Extraction complete 2 (0) 8 (1)
comparator, outcomes) was the next highest scoring item with 
386 (89%) reporting all of these elements. Selection proc-
ess (214, 49%), describing the criteria under which study data 
will be quantitatively synthesized (200, 46%), and describ-
ing the type of summary planned if quantitative synthesis is not 
appropriate (227, 52%) were the next highest scoring of the 19 
items assessed.
The scores by PRISMA-P item and by breakdown of items 
are presented in Table 2. The full dataset with assessment out-
comes and scores for individual records, and the subgroup 
analyses scoring are available on the OSF (Underlying data16).
Scoring for 63 elements of the PRISMA-P items
The score for some of the 19 items was reduced as a result 
of just one or two of the constituent elements being omitted 
from reports while others were relatively regularly identified.
Although overall the review question (item 7) was not found 
to contain all the expected elements, most did specify the ele-
ments of population (397, 92%) and the intervention (416, 96%) 
and just over half included the outcomes (237, 55%). The com-
parator was less frequently included (142, 33%); this may have 
been because of the intention of the review but where 
this was clear, the item was scored as not applicable 
(6%).
Information sources (item 9) was scored as completed in only 
two records (1%) overall; however, for the individual elements 
431 (99%) did name the electronic databases to be searched, 
289 (67%) said whether they planned to search study registries, 
and 238 (55%) indicated search dates. In item 10, provision 
of a draft search strategy (91, 21%) or search terms (100, 23%) 
was poor; but restrictions such as to English language papers 
were reported in 332 (77%).
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Demographic Records for assessment 
(n = 439)
Records not assessed 
(n = 1755)
Topic of review*** 
n (%)
Alcohol/substance misuse/abuse 12 (3) 28 (2)
Blood and immune system 13 (3) 90 (5)
Cancer 42 (10) 182 (10)
Cardiovascular 61 (14) 220 (13)
Care of the elderly 16 (4) 72 (4)
Child health 31 (7) 139 (8)
Complementary therapies 43 (10) 178 (10)
Crime and justice 0 (0) 2 (0)
Dental 30 (7) 138 (8)
Digestive system 34 8) 127 (7)
Ear, nose and throat 7 (2) 27 (2)
Education 10 (2) 23 (1)
Endocrine and metabolic disorders 35 (8) 144 (8)
Eye disorders 3 (1) 16 (1)
General interest 5 (1) 29 (2)
Genetics 3 (1) 5 (0)
Health inequalities/health equity 3 (1) 8 (1)
Infections and infestations 22 (5) 97 (6)
International development 0 (0) 2 (0)
Mental health and behavioural conditions 51 (12) 129 (7)
Musculoskeletal 70 (16) 253 (14)
Neurological 44 (10) 208 (12)
Nursing 11 (3) 45 (3)
Obstetrics and gynaecology 23 (5) 101 (6)
Oral health 21 (5) 100 (6)
Palliative 4 (1) 16 (1)
Perioperative care 14 (3) 81 (5)
Physiotherapy 36 (8) 129 (7)
Pregnancy and childbirth 13 (3) 60 (3)
Public Health 0 (0) 0 (0)
Rehabilitation 43 (10) 173 (10)
Respiratory disorders 16 (4) 87 (5)
Service delivery 0 (0) 0 (0)
Skin disorders 12 (3) 40 (2)
Social care 0 (0) 2 (0)
Surgery 49 (11) 209 (12)
Tropical medicine 0 (0) 0 (0)
Urological 20 (5) 71 (4)
Wounds, injuries and accidents 11 (3) 70 (4)
Violence and abuse 3 (1) 10 (1)
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Demographic Records for assessment 
(n = 439)
Records not assessed 
(n = 1755)
Country of review*** 
n (%)
Australia 33 (8) 143 (8)
Brazil 53 (12) 224 (13)
Canada 38 (9) 121 (7)
China 100 (23) 414 (24)
England 46 (10) 163 (9)
Germany 13 (3) 40 (2)
Italy 14 (3) 62 (4)
Netherlands 13 (3) 51 (3)
Spain 13 (3) 39 (2)
USA 48 (11) 160 (9)
57 other countries 127 (29) 562 (32)
* the record with 47 authors was a single outlier: range excluding this record was 0-15
** details for three records were not available on PROSPERO
*** all items reported by authors included; therefore totals are more than the number of records
Table 2. Assessment scores by item and breakdown for 433 PROSPERO records.
PRISMA-P reporting item
Reported 
or not 
applicable
Not 
reported Breakdown of items Reported
Not 
reported
Not 
applicable
Section 1 Administrative information
1a. Identification in the title: 
Identify the report as a protocol of 
a systematic review 22 (5) 411 (95)
Identify the report as a 
protocol
22 (5) 411 (95) /
Identify the report as a 
systematic review
342 (79) 91 (21) /
1b. Update: If the protocol is 
for an update of a previous 
systematic review
424 (98) 9 (2) Identify the report as an 
update
1 (0) 9 (2) 423 (98)
Section 2 Introduction
6. Rationale: Describe the 
rationale for the review in the 
context of what is already known
38 (9) 395 (91)
Rationale described 44 (10) 389 (90) /
Context provided* 108 (25) 325 (75) /
7. Objectives: Provide an explicit 
statement of the question(s) the 
review will address with reference 
to participants, interventions, 
comparators, and outcomes 
(PICO)*
134 (31) 299 (69)
Population 397 (92) 36 (8) /
Intervention 416 (96) 17 (4) /
Comparator 142 (33) 264 (61) 27 (6)
Outcomes 237 (55) 196 (45) /
Section 3 Methods
8. Eligibility criteria: Specify the 
study characteristics (e.g., PICO, 
study design, setting, time frame) 
and report characteristics (e.g., 
years considered, language, 
publication status) to be used as 
criteria for eligibility for the review*
386 (89) 47 (11)
Study design specified* 427 (99) 6 (1) /
Setting (condition or 
domain) specified*
410 (95) 23 (5) /
Population* 429 (99) 4 (1) /
Intervention* 428 (99) 5 (1) /
Comparator* 392 (91) 14 (3) 27 (6)
Outcome(s)* 424 (98) 9 (2) /
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PRISMA-P reporting item
Reported 
or not 
applicable
Not 
reported Breakdown of items Reported
Not 
reported
Not 
applicable
9. Information sources: Describe 
all intended information sources 
(e.g., electronic databases, 
contact with study authors, trial 
registers, or other grey literature 
sources) with planned dates of 
coverage*
2 (1) 431 (99)
Electronic database(s) 
named
431 (99) 2 (1) /
Grey literature sources 100 (23) 333 (77) /
Study registries 289 (67) 144 (33) /
Contact with study authors 
planned or statement that 
contact not planned
27 (6) 406 (94) /
Other: e.g. hand searching 
reference lists of included 
studies
152 (35) 281 (65) /
Planned search dates 238 (55) 195 (45) /
10. Search strategy: Present draft 
of search strategy to be used for 
at least one electronic database, 
including planned limits, such that 
it could be repeated 75 (17) 358 (83)
Draft search strategy 
provided
91 (21) 342 (79) /
Search terms given alone 100 (23) 242 (56) 91 (21)
Approach to limits/
restrictions reported 
e.g. language or dates/
statement of no limits*
332 (77) 101 (23) /
11a. Data management: Describe 
the mechanism(s) that will be 
used to manage records and data 
throughout the review
17 (4) 416 (96)
Software named/type 
indicated*
56 (13) 377 (87) /
De-duplication planned 42 (9) 391 (91) /
11b. Selection process: State 
the process that will be used 
for selecting studies (e.g., two 
independent reviewers) through 
each phase of the review (i.e., 
screening, eligibility, and inclusion 
in meta-analysis)
214 (49) 219 (51)
Initial screening process 
described*
232 (54) 201 (46) /
Full paper screening 
process described*
219 (51) 214 (49) /
11c. Data collection process: 
Describe planned method of 
extracting data from reports 
(e.g., piloting forms, done 
independently, in duplicate), 
any processes for obtaining 
and confirming data from 
investigators*
50 (12) 383 (88)
Data extraction form 169 (39) 264 (61) /
Data extraction process 
described
258 (60) 175 (40) /
Obtain missing data 76 (18) 357 (82) /
12. Data items: List and define all 
variables for which data will be 
sought (e.g., PICO items, funding 
sources), any pre-planned data 
assumptions and simplifications
6 (1) 427 (99)
List of data for extraction* 219 (51) 214 (49) /
Variables defined* 29 (7) 404 (93) /
Any data assumptions 
reported
17 (4) 416 (96) /
13. Outcomes and prioritisation: 
List and define all outcomes 
for which data will be sought, 
including prioritisation of main 
and additional outcomes, with 
rationale
3 (1) 430 (99)
Primary/main outcome(s)* 
specified as such
418 (97) 15 (3) /
Primary/main outcome(s) 
measure specified*
235 (54) 198 (46) /
Additional outcomes 
specified/ state None*
430 (99) 3 (1) /
Additional outcomes: 
measures specified*
131 (30) 180 (42) 122 (28)
Rationale for choice of 
outcome(s)
8 (2) 425 (98) /
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PRISMA-P reporting item
Reported 
or not 
applicable
Not 
reported Breakdown of items Reported
Not 
reported
Not 
applicable
14. Risk of bias in individual 
studies: Describe anticipated 
methods for assessing risk of bias 
of individual studies, including 
whether this will be done at the 
outcome or study level, or both; 
state how this information will be 
used in data synthesis*
41 (9) 392 (91)
No risk of bias assessment 
planned, and justification 
provided
4 (1) 3 (1) 426 (98)
Risk of bias tools named 
for all study types included
362 (84) 67 (16) 4 (1)
Outcome or study level 
or both
310 (71) 119 (28) 4 (1)
Domains/outcomes for risk 
of bias assessment stated
342 (79) 87 (20) 4 (1)
Risk of bias assessment 
process described
296 (68) 133 (31) 4 (1)
How risk of bias findings 
will be used in the 
synthesis
64 (15) 365 (84) 4 (1)
15a. Synthesis: Describe criteria 
under which study data will be 
quantitatively synthesized
200 (46) 233 (54) Criteria for doing a 
quantitative synthesis/
meta-analysis described*
131 (30) 233 (54) 69 (16)
15b. If data are appropriate for 
quantitative synthesis, describe 
planned summary measures, 
methods of handling data, and 
methods of combining data from 
studies, including any planned 
exploration of consistency (e.g., 
I2, Kendall’s tau) 70 (16) 363 (84)
Summary measures* 202 (46) 163 (38) 68 (16)
Statistical method* 89 (20) 276 (64) 68 (16)
Use of fixed or random 
effects or both*
194 (44) 171 (40) 68 (16)
Data handling: conversion 
to same format
106 (24) 259 (60) 68 (16)
Data handling: missing 
data
14 (3) 351 (81) 68 (16)
Combining data/ 
exploration of consistency
179 (41) 186 (43) 68 (16)
Name of software to be 
used for meta-analysis
204 (47) 161 (37) 68 (16)
15c. Describe any proposed 
additional analyses (e.g., 
sensitivity or subgroup analyses, 
meta-regression)
84 (19) 349 (81)
Subgroup analyses 
planned: co-variants 
named*
344 (79) 21 (5) 68 (16)
Methods for subgroup 
analyses reported
25 (6) 280 (65) 128 (29)
Sensitivity analyses 
planned
85 (19) 280 (65) 68 (16)
15d. If quantitative synthesis is not 
appropriate, describe the type of 
summary planned*
227 (52) 206 (48)
Descriptive, narrative, 
or qualitative synthesis 
planned
194 (45) 55 (12) 184 (43)
Descriptive, narrative 
or qualitative synthesis 
methods described
49 (11) 200 (46) 184 (43)
Other analyses planned 3 (1) 11 (3) 419 (96)
16. Meta-bias(es): Specify any 
planned assessment of meta-
bias(es) (e.g., publication bias 
across studies, selective reporting 
within studies)
72 (17) 361 (83)
Publication bias to be 
assessed
94 (21) 271 (63) 68 (16)
Outcome reporting bias to 
be assessed
4 (1) 361 (83) 68 (16)
17. Confidence in cumulative 
evidence: Describe how the 
strength of the body of evidence 
will be assessed (e.g., GRADE)
37 (9) 396 (91)
Overall assessment of 
included studies planned
40 (9) 393 (91) /
Methods specified 38 (9) 395 (91) /
* Item/element required in PROSPERO *Item/element identified in PROSPERO but as optional
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Reporting of item 13, outcomes, scored badly overall (3, 1%) as, 
although the outcomes were included in most records (Primary 
418, 97%; Secondary 430, 99%) only 8 (2%) were assessed as 
having provided a rationale for their choice of outcomes. Simi-
larly, in item 14, the absence of information on how the risk of 
bias would be used in the synthesis, detracted from the high 
rate of inclusion of risk of bias tools and use. Reporting of 
the details for a quantitative synthesis, item 15b, had one ele-
ment with a very low score (handling missing data, 14, 3%), the 
other six elements scored between 89 (20%) and 204 (47%).
In three items, the overall score reflected the general picture 
from the included elements. In item 6, rationale, both the rea-
son for undertaking the review and the context were infrequently 
identified. PRIMSA-P items 16, meta-bias(es) and 17, confi-
dence in cumulative evidence, were rarely reported. Only con-
text is classified as optional information in PROSPERO, the 
remainder of these elements are not explicitly requested.
There appears to be a trend towards higher frequency of report-
ing of elements that are mandatory in PROSPERO, for exam-
ple, in the eligibility criteria (item 8) and risk of bias (item 14). 
The trend is also seen in item 13, the required specification of 
primary and secondary outcomes, both frequently reported, 
but with a drop in specifying measures, which was optional.
Subgroup comparisons
The subgroup comparisons investigated the stage of review at 
registration; whether or not information was reported on source 
of funding, sponsorship or support and where none was indi-
cated; and whether or not the relevant box in the registration 
form had been ticked to indicate a meta-analysis was 
planned.
There were no differences in total scores for the 19 PRISMA-P 
items or the 63 elements, between those records registered 
before screening against eligibility criteria had started and 
those records registered after screening had commenced. This 
held true for the mean, standard deviation, median and range 
of scores.
A 6% difference was seen in the total score achieved for the 
meta-analysis (23%) vs no meta-analysis (29%) groups in the 
assessment of the 19 PRISMA-P items. The difference was 
reduced to 2% when considering the breakdown of 63 ele-
ments within the reported items (52% vs 54%). At both item 
and element level, the group of records with no planned 
meta-analysis scored slightly higher, but with a higher 
standard deviation from the mean and wider range of scores 
achieved.
Across all results for both the 19 items and 63 elements, the 
group with funding, sponsorship or support, scored slightly 
higher than those not receiving funding, sponsorship or support.
The results of the subgroups investigated are presented in 
Table 3. The subgroup scores by individual PRISMA-P 
reporting item are available on the OSF (Underlying data16).
Table 3. Subgroup comparisons.
Subgroup Variable No. of 
records
Total 
possible 
score
Total score 
achieved 
N (%)
Mean 
score 
(SD)
Median 
score
Range of 
scores
For 19 PRISMA-P reporting items
Stage of review at 
registration
Before 
screening 
started
245 4655 1181 (25) 4.8 (1.9) 5 2–11
After screening 
started
188 3572 900 (25) 4.8 (1.8) 4 2–10
Meta-analysis planned M-A 250 4750 1088 (23) 4.4 (1.5) 4 2–9
No M-A 183 3477 993 (29) 5.4 (2.1) 5 2–11
Funded / Sponsored / 
Supported
Funded etc. 381 7239 1841 (25) 4.8 (1.9) 4 2–11
Not funded etc. 52 988 240 (24) 4.6 (1.6) 4 2–8
For 63 PRISMA-P reporting elements
Stage of review at 
registration
Before 
screening 
started
245 15435 8214 (53) 33.5 (5.9) 33 18–47
After screening 
started
188 11844 6255 (53) 33.3 (5.8) 33 21–47
Meta-analysis M-A 250 15750 8244 (52) 33.0 (5.2) 32 21–45
No M-A 183 11529 6225 (54) 34.0 (6.6) 34 18–47
Funded / Sponsored / 
Supported
Funded etc. 381 24003 12804 (53) 33.6 (5.9) 33 18–47
Not funded etc. 52 3276 1665 (51) 32.0 (5.3) 31 22–46
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We present the scores by the 19 PRISMA-P items and by 
the breakdown of 63 elements for the ten countries and top-
ics with the highest number of assessed records, and for number 
of authors listed in Table 4. None of these factors appear to 
have a marked influence on the number of PRISMA-P items or 
elements reported in PROSPERO records.
Discussion
Publication and registration of a systematic review protocol pro-
vides transparency in the review process, allowing readers to 
see the efforts made to minimise biases and where biases may 
still have influenced the final review findings. There is empiri-
cal evidence that few of the protocol registrations in PROSPERO 
Table 4. Overall scores by country, number of authors and topic of review.
No of 
records
For the 19 PRISMA-P items assessed For the 63 elements assessed
Overall score 
(% of possible 
score)
Mean 
score 
(SD)
Median 
score
Range of 
scores
Overall 
score (% 
of possible 
score)
Mean 
score 
(SD)
Median 
score
Range of 
scores
Country (10 with most assessed records)
Australia 33 179 (28) 5.4 (2.1) 5 2–11 1115 (54) 33.8 (6.2) 32 21–47
Brazil 53 272 (27) 5.1 (1.9) 5 2–9 1826 (55) 34.5 (6.0) 35 18–46
Canada 37* 197 (28) 5.3 (2.1) 5 2–9 1301 (56) 35.2 (6.7) 35 21–45
China 101 418 (22) 4.1 (1.3) 4 2–10 3385 (54) 33.5 (4.5) 34 23–45
England 46 259 (29) 5.6 (2.2) 5 2–10 1620 (55) 35.2 (6.9) 35.5 22–47
Germany 11* 59 (28) 5.4 (2.3) 4 3–10 380 (55) 34.5 (6.2) 33 26–47
Italy 15 71 (27) 4.7 (1.8) 4 3–9 499 (57) 33.3 (6.2) 32 24–47
Netherlands 13 68 (28) 5.2 (2.1) 5 2–9 439 (53) 33.8 (7.0) 33 23–47
Spain 13 64 (26) 4.9 (1.8) 4 2–7 426 (52) 32.8 (5.6) 33 22–42
USA 48 242 (27) 5.0 (2.2) 4 2–10 1526 (51) 31.8 (6.4) 31 21–47
Number of authors
0–3 202 956 (25) 4.7 (1.8) 4 2–10 6648 (52) 32.9 (5.9) 32 18–47
4–6 179 867 (25) 4.8 (1.9) 5 2–11 6008 (53) 33.6 (5.7) 34 21–47
7+ 52 258 (27) 5.0 (1.9) 4 2–9 1813 (56) 34.9 (5.9) 34 21–47
Topic of review (10 with most assessed records)
Cancer 42 184 (23) 4.4 (1.8) 4 2–10 1326 (50) 31.6 (5.6) 31 21–47
Cardiovascular 58* 278 (25) 4.8 (1.8) 4 2–10 1952 (53) 33.7 (5.5) 33 21–46
Complementary 
therapies
43 211 (26) 4.9 (1.8) 5 2–9 1511 (56) 35.1 (6.0) 36 22–44
Endocrine 
and metabolic 
disorders
34* 175 (27) 5.1 (2.1) 5 2–10 1204 (56) 35.4 (6.1) 36 21–47
Mental health 
and behavioural 
conditions
51 266 (27) 5.2 (2.0) 5 2–10 1762 (55) 34.5 (5.7) 33 21–44
Musculoskeletal 70 335 (25) 4.8 (2.0) 4 2–11 2295 (52) 32.8 (6.2) 32 18–47
Neurological 42* 221 (28) 5.3 (1.9) 5 2–11 1443 (55) 34.4 (6.1) 33.5 23–47
Physiotherapy 36 174 (25) 4.8 (1.8) 4 2–8 1194 (53) 33.2 (5.8) 32.5 18–43
Rehabilitation 42* 201 (25) 4.8 (2.1) 4 2–11 1393 (53) 33.2 (5.7) 32.5 23–47
Surgery 49 251 (27) 5.1 (1.8) 5 2–10 1644 (53) 33.6 (5.2) 33 23–47
*numbers differ from Table 1 because of the record(s) excluded at assessment
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have a corresponding published report9. Where there is no pro-
tocol, the registration provides the only public record of what 
was originally planned. This study set out to establish to what 
extent PROSPERO registrations of systematic review protocols 
of healthcare interventions reported on items in the PRISMA-P 
reporting guidelines.
Using a random sample of 433 PROSPERO records from 2018, 
two researchers independently assessed the frequency of report-
ing of 19 PRISMA-P items, with 63 individual elements. The 
results show that while some key methodological details are 
relatively frequently reported, much of the information recom-
mended in PRISMA-P is missing. Reporting was unsurprisingly 
more frequent for items that are mandatory in PROSPERO than 
those that are optional. Comparisons by stage of review at reg-
istration, whether meta-analysis was planned and whether 
funding or sponsorship was reported showed no meaning-
ful differences between groups. The slight difference between 
groups with a planned meta-analysis or none may be because 
in PRISMA-P more details are specified for the reporting of a 
meta-analysis than for a descriptive, narrative or qualitative 
analysis. 
Eligibility criteria and type of analysis planned were most fre-
quently reported and are all separate required fields in PROS-
PERO. However, study selection process, which is optional, was 
also a higher frequency reported item. This may be explained by 
considering that some elements of items, such as eligibility crite-
ria, study selection and risk of bias have what might be consid-
ered a standard, recognisable format that facilitates reporting. 
Other items need a more nuanced approach underpinned by a 
clear understanding of systematic review methods, and there-
fore may be associated with being less frequently reported 
due to a lack of confidence or experience with these aspects 
of review methods. For example, how risk of bias will be used 
in the synthesis, data handling in a meta-analysis, meta-biases 
and confidence in cumulative evidence, all had low scores. Part 
of the problem may be the uncertainty of what the searches will 
find when designing a systematic review but needing to know 
so the design is appropriate. For example, the intention may 
be to perform a meta-analysis, this may not be possible once the 
studies for inclusion have been identified. While, both PROS-
PERO and PRISMA-P acknowledge that protocols are itera-
tive documents and may need to be amended, changes should 
be documented, justified and the stage of review at the time 
of the amendment made clear. Therefore, it is better to record 
alternative options for activities such as how data will be ana-
lysed and the conditions for selection of option when finalising 
the protocol.
Differences in frequency of reporting may also reflect where 
researchers considered items to be less or more impor-
tant than others. For example, naming the software used for 
data management may not be seen as crucial, whereas the 
eligibility criteria and approach to synthesis are.
There are strengths and limitations to this study. The assessed 
sample of 433 records was representative of all the eligible 
2018 non-Cochrane intervention reviews registered in PROS-
PERO. As a result, the findings may reasonably be general-
ised to other registrations of healthcare interventions, but not 
necessarily other types of registered reviews excluded from 
our sample.
PRISMA-P is a reporting guideline and not a rating scale, so 
judgements about whether sufficient information had been pro-
vided for some items carried a degree of subjectivity. The assess-
ment guide and form developed for the study aimed to maximise 
objectivity but in accordance with PRISMA-P did not weight 
importance of items. Although two researchers independently 
carried out the assessments, achieving an overall agreement 
rate of 90%, subjectivity was minimised but not eliminated.
PROSPERO was developed in 2011 to record key protocol 
details and does not necessarily accord with everything subse-
quently recommended in the 2015 PRISMA-P reporting guide-
lines. Some registration items are mandatory and others optional. 
However, this study looked at records that had no other protocol 
output and arguably should therefore have provided PRISMA-P 
level detail. The evidence that protocol details are only 
available in PROSPERO for around 96% of non-Cochrane 
reviews makes the infrequency of reporting of items a concern9,10. 
Based on the findings of other studies, promoting improved 
reporting of protocol details may help increase the quality of 
systematic reviews17,18.
Protocols are iterative documents and even after a review has 
started there may be legitimate reasons for amendments. Such 
changes should and can be reported in a registration record, 
with their justification and timing. Just over two thirds of 
PROSPERO records have more than one version (Figure 1). 
While focussing on single entry records to be certain that any 
changes were not made after completion of the review this 
may have excluded records where more complete information 
was added to the record over time at key points in the review 
process.
This study simply looked at whether items were reported and 
not at the level of detail or suitability/appropriateness of the 
planned methods. The option of ‘partially reported’ could have 
been used at assessment but was avoided to minimise subjectiv-
ity. The focus was on simply establishing whether items were 
reported or not. The assessors focussed on whether the informa-
tion was reported or could reasonably be inferred from what 
was reported. Assessing the quality of planned methods in 
protocol registrations needs to be the subject of further research.
This study shows that there is work to be done to promote the 
complete reporting of items recommended in the guidelines for 
systematic review protocols when the registration in PROSPERO 
is the only place they can be accessed. This is in line with other 
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research that has identified issues with the quality of reporting, 
publication and outcome reporting biases in systematic review 
protocols in general3,9,11,13,19,20. As proposed in the PRISMA-P 
statement paper, actions and potential benefits to encour-
age adherence to PRISMA-P will take a joint effort on the 
part of a host of stakeholders, including reviewers, registries, 
and journal editors5,21.
Conclusions
PROSPERO provides reviewers with the opportunity to be 
transparent in their planned methods and demonstrate efforts 
to reduce bias. However, where the PROSPERO record is 
the only available source of a priori reporting, there is a sig-
nificant shortfall in the items reported, compared to those 
recommended in PRISMA-P. This presents peer reviewers and 
others wishing to assess the validity of the final review with 
challenges in interpretation. PROSPERO records are not peer 
reviewed or assessed for methodological quality, it is the respon-
sibility of those registering their review to complete the reg-
istration form fully or provide access to a complete protocol. 
There are several areas requiring particular attention when 
completing the registration form. These include explaining the 
rationale for undertaking the review in the context of what is 
known; providing information sources beyond a list of data-
bases to be searched; and reporting reproducible process meth-
ods for data management, study selection and risk of bias 
assessment. In addition, defining variables for data extrac-
tion, how specified outcomes will be measured, and the planned 
analyses, with criteria for undertaking a quantitative synthesis 
should all be included in detail.
This study only looked at whether recommended items were 
reported or not in PROSPERO records. Further research 
is needed to assess the quality of the planned methods in 
systematic review protocol registrations.
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2SHQ3HHU5HYLHZ
&XUUHQW3HHU5HYLHZ6WDWXV  
9HUVLRQ
5HYLHZHU5HSRUWb$XJXVW
KWWSVGRLRUJIUHVHDUFKU
k6XQ;7KLVLVDQRSHQDFFHVVSHHUUHYLHZUHSRUWGLVWULEXWHGXQGHUWKHWHUPVRIWKH&UHDWLYH&RPPRQV
$WWULEXWLRQ/LFHQVHZKLFKSHUPLWVXQUHVWULFWHGXVHGLVWULEXWLRQDQGUHSURGXFWLRQLQDQ\PHGLXPSURYLGHGWKH
RULJLQDOZRUNLVSURSHUO\FLWHG
;LQ6XQ 
&KLQHVH(YLGHQFH%DVHG0HGLFLQH&HQWHUDQG&RFKUDQH&KLQD&HQWHU:HVW&KLQD+RVSLWDO
6LFKXDQ8QLYHUVLW\&KHQJGX&KLQD
7KLVVWXG\FRQGXFWHGDPHWKRGRORJLFDOVXUYH\WRDVVHVVWKHH[WHQWWRZKLFKWKHFRQWHQWVRI
35263(52UHFRUGVPHHWWKHV\VWHPDWLFUHYLHZSURWRFROUHSRUWLQJLWHPVLQ35,60$37KLVSDSHU
DGGUHVVHVDQLPSRUWDQWUHVHDUFKTXHVWLRQDQGWKHILQGLQJVPD\KDYHLPSOLFDWLRQVIRUWKH
UHSRUWLQJRIV\VWHPDWLFUHYLHZSURWRFROV+RZHYHUWKHUHDUHDIHZLVVXHVIRUDXWKRUVWRFRQVLGHU
2QHDLPRI35,60$3LVWRDLGDXWKRUVLQWUDQVLWLRQLQJWKHLUV\VWHPDWLFUHYLHZSURWRFROV
SUHSDUHGLQDFFRUGDQFHZLWK35,60$3LQWRIXOOWH[WZKLOHWKHDXWKRUVXVHGUHFRUGVIURP
35263(52LHQRWIXOOWH[WWRDVVHVVWKHFRPSOLDQFHWR35,60$3UHSRUWLQJLWHPVZKLFK
PD\EHDOLPLWDWLRQWKDWVKRXOGEHGLVFXVVHGLQWKLVSDSHU
b

,QWKHPHWKRGVSDUWLWFRXOGEHGHVLUDEOHWKDWWKHDXWKRUVFRXOGFOHDUO\UHSRUWKRZWKH
QXPEHUHGLWHPVRI35,60$3ZHUHEURNHQGRZQLQWRHOHPHQWV
b

7KHDXWKRUVKRXOGFOHDUO\UHSRUWZKHWKHUWKHVXEJURXSDQDO\VHVUHSRUWHGLQWDEOHZHUH
SUHSODQQHG
b

7KHXVHRIDVFRULQJVFKHPHIRU35,60$3DQGWKHHOHPHQWVPD\QRWEHRSWLPDOJLYHQ
WKHSRWHQWLDOGLIIHUHQFHLQLWHPLPSRUWDQFHZKLFKVKRXOGEHDGGHGWRWKHGLVFXVVLRQSDUW
DVDOLPLWDWLRQ
b

,QWDEOHYDOXHVLQSDUHQWKHVHVDUHSHUFHQWDJHVZKLFKVKRXOGEHLQGLFDWHGLQWKHWDEOH

,VWKHZRUNFOHDUO\DQGDFFXUDWHO\SUHVHQWHGDQGGRHVLWFLWHWKHFXUUHQWOLWHUDWXUH"
<HV
,VWKHVWXG\GHVLJQDSSURSULDWHDQGLVWKHZRUNWHFKQLFDOO\VRXQG"
<HV
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$UHVXIILFLHQWGHWDLOVRIPHWKRGVDQGDQDO\VLVSURYLGHGWRDOORZUHSOLFDWLRQE\RWKHUV"
<HV
,IDSSOLFDEOHLVWKHVWDWLVWLFDODQDO\VLVDQGLWVLQWHUSUHWDWLRQDSSURSULDWH"
3DUWO\
$UHDOOWKHVRXUFHGDWDXQGHUO\LQJWKHUHVXOWVDYDLODEOHWRHQVXUHIXOOUHSURGXFLELOLW\"
<HV
$UHWKHFRQFOXVLRQVGUDZQDGHTXDWHO\VXSSRUWHGE\WKHUHVXOWV"
<HV
&RPSHWLQJ,QWHUHVWV1RFRPSHWLQJLQWHUHVWVZHUHGLVFORVHG
5HYLHZHU([SHUWLVH&OLQLFDOb(SLGHPLRORJ\
,FRQILUPWKDW,KDYHUHDGWKLVVXEPLVVLRQDQGEHOLHYHWKDW,KDYHDQDSSURSULDWHOHYHORI
H[SHUWLVHWRFRQILUPWKDWLWLVRIDQDFFHSWDEOHVFLHQWLILFVWDQGDUG
5HYLHZHU5HSRUWb-XO\
KWWSVGRLRUJIUHVHDUFKU
k3LHSHU'7KLVLVDQRSHQDFFHVVSHHUUHYLHZUHSRUWGLVWULEXWHGXQGHUWKHWHUPVRIWKH&UHDWLYH&RPPRQV
$WWULEXWLRQ/LFHQVHZKLFKSHUPLWVXQUHVWULFWHGXVHGLVWULEXWLRQDQGUHSURGXFWLRQLQDQ\PHGLXPSURYLGHGWKH
RULJLQDOZRUNLVSURSHUO\FLWHG
'DZLG3LHSHU 
)DFXOW\RI+HDOWK'HSDUWPHQWRI0HGLFLQH8QLYHUVLW\:LWWHQ+HUGHFNH&RORJQH*HUPDQ\
7KLVDUWLFOHLVDQDQDO\VLVRIKRZ35263(52UHFRUGVDGKHUHWRWKH35,60$3JXLGHOLQH7KH
$QDO\VLVLVEDVHGRQDUDQGRPVDPSOHRI35263(52UHFRUGVSXEOLVKHGLQ7KHDXWKRUV
FRQFOXGHWKDWUHSRUWLQJLQ35263(52VKRXOGEHLPSURYHGJLYHQWKHIDFWWKDWWKH35263(52
UHFRUGLVRIWHQWKHRQO\DYDLODEOHVRXUFHRIDSULRULUHSRUWLQJ

7KHPDQXVFULSWLVPHWKRGRORJLFDOO\VRXQGDQGZHOOZULWWHQ:KDW,WKLQNFDQEHLPSURYHGLVWKH
GLVFXVVLRQ,ZRQGHUZKDWLVWKHLPSOLFDWLRQRIWKLVVWXG\'RWKHDXWKRUVZDQWWRPDNHWKHSRLQW
WKDW35263(52UHFRUGVVKRXOGIROORZ35,60$3"7RWKHEHVWbRIP\NQRZOHGJH35,60$3LVHYHQ
QRWPHQWLRQHGLQWKHb35263(52JXLGDQFHb,IWKLVZRXOGEHWKHLQWHQWLRQWKHQZ\QRWDOOLJQ
35263(52ZLWKWKH35,60$3LWHPVb,DGPLWWKDW35,60$3KDVEHHQSULPDULO\GHVLJQHGIRU65VRI
KHDOWKFDUHLQWHUYHQWLRQVEXWPRVWLWHPVDUH*HQHUDODQGZRXOGEHDSSOLFDEOHWRRWKHUUHYLHZ
W\SHVDVZHOOb,GRQRWZDQWWRPDNHWKHSRLQWWKDWWKLVbLVDJUHDWbLGHDEXWLWLVVRPHKRZDORJLFDO
TXHVWLRQbUHVXOWLQJIURP\RXUPDQXVFULSWDQGWKLVVKRXOGEHPHQWLRQHGLQWKHGLVFXVVLRQ
5HJLVWULHVDQGSURWRFROVVKRXOGEHVHHQDVGLIIHUHQWHQWLWLHVDQGWKXV,WKLQNWKDWDSHUIHFWUHVXOW
RIDOO35263(52UHFRUGVPHHWLQJDOO35,60$3LWHPVFDQQRWEHZKDWZHDLPLQJIRU,IWKLVZRXOG
EHWKHFDVHWKLVZRXOGSUREDEO\GLOXWHWKHGLIIHUHQFHEHWZHHQD35263(52UHFRUGDQGDSURWRFRO

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,VWKHZRUNFOHDUO\DQGDFFXUDWHO\SUHVHQWHGDQGGRHVLWFLWHWKHFXUUHQWOLWHUDWXUH"
<HV
,VWKHVWXG\GHVLJQDSSURSULDWHDQGLVWKHZRUNWHFKQLFDOO\VRXQG"
<HV
$UHVXIILFLHQWGHWDLOVRIPHWKRGVDQGDQDO\VLVSURYLGHGWRDOORZUHSOLFDWLRQE\RWKHUV"
<HV
,IDSSOLFDEOHLVWKHVWDWLVWLFDODQDO\VLVDQGLWVLQWHUSUHWDWLRQDSSURSULDWH"
1RWDSSOLFDEOH
$UHDOOWKHVRXUFHGDWDXQGHUO\LQJWKHUHVXOWVDYDLODEOHWRHQVXUHIXOOUHSURGXFLELOLW\"
<HV
$UHWKHFRQFOXVLRQVGUDZQDGHTXDWHO\VXSSRUWHGE\WKHUHVXOWV"
3DUWO\
&RPSHWLQJ,QWHUHVWV1RFRPSHWLQJLQWHUHVWVZHUHGLVFORVHG
5HYLHZHU([SHUWLVH5HVHDUFKPHWKRGVFOLQLFDOHSLGHPLRORJ\
,FRQILUPWKDW,KDYHUHDGWKLVVXEPLVVLRQDQGEHOLHYHWKDW,KDYHDQDSSURSULDWHOHYHORI
H[SHUWLVHWRFRQILUPWKDWLWLVRIDQDFFHSWDEOHVFLHQWLILFVWDQGDUG
7KHEHQHILWVRISXEOLVKLQJZLWK)5HVHDUFK
<RXUDUWLFOHLVSXEOLVKHGZLWKLQGD\VZLWKQRHGLWRULDOELDVȎ
<RXFDQSXEOLVKWUDGLWLRQDODUWLFOHVQXOOQHJDWLYHUHVXOWVFDVHUHSRUWVGDWDQRWHVDQGPRUHȎ
7KHSHHUUHYLHZSURFHVVLVWUDQVSDUHQWDQGFROODERUDWLYHȎ
<RXUDUWLFOHLVLQGH[HGLQ3XE0HGDIWHUSDVVLQJSHHUUHYLHZȎ
'HGLFDWHGFXVWRPHUVXSSRUWDWHYHU\VWDJHȎ
)RUSUHVXEPLVVLRQHQTXLULHVFRQWDFWUHVHDUFK#IFRP
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